Education
About Us
Working with TipRanks
Follow Us
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.71, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.71, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.81, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.71, making it a Sell.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
0.70
0.71
0.74
0.75
0.78
0.79
0.82
Fibonacci
0.71
0.73
0.74
0.75
0.77
0.78
0.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
0.75Sell
0.74Sell
MA10
0.72Sell
0.72Sell
MA20
0.67Buy
0.71Sell
MA50
0.83Sell
0.81Sell
MA100
0.98Sell
1.00Sell
MA200
1.34Sell
1.39Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.72, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.71, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 1.00, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.71, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.71 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.83, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.71 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.98, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.71 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 1.34, creating a Sell signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
47.58
Neutral
STOCH (9,6)
82.57
Sell
STOCHRSI (14)
87.40
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
27.04
Neutral
Williams %R
-30.85
Buy
CCI (14)
79.69
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
62.01
Neutral
ROC
14.52
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 47.58, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 27.04, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 79.69, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 14.52, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Sell.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 47.58, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is >-0.01, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 0.75, which suggests BCLI is a Sell.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 0.67, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 0.83, which suggests BCLI is a Sell.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 1.34, which suggests BCLI is a Sell.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -30.85, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 79.69, which suggests BCLI is a Neutral.